These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38175635)

  • 21. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012.
    Harvey AR; Basavaraju SV; Chung KW; Kuehnert MJ
    Transfusion; 2015 Apr; 55(4):709-18. PubMed ID: 25371300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion-Transmitted Infections Reported to the National Healthcare Safety Network Hemovigilance Module.
    Haass KA; Sapiano MRP; Savinkina A; Kuehnert MJ; Basavaraju SV
    Transfus Med Rev; 2019 Apr; 33(2):84-91. PubMed ID: 30930009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.
    Hong H; Xiao W; Lazarus HM; Good CE; Maitta RW; Jacobs MR
    Blood; 2016 Jan; 127(4):496-502. PubMed ID: 26598718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial contamination of whole-blood-derived platelets: the introduction of sample diversion and prestorage pooling with culture testing in the American Red Cross.
    Benjamin RJ; Kline L; Dy BA; Kennedy J; Pisciotto P; Sapatnekar S; Mercado R; Eder AF
    Transfusion; 2008 Nov; 48(11):2348-55. PubMed ID: 18657074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.
    Daurat A; Roger C; Gris J; Daurat G; Feissel M; Le Manach Y; Lefrant J; Muller L
    Transfusion; 2016 Jun; 56(6):1295-303. PubMed ID: 26814984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and implementation of a hemovigilance program at a university veterinary teaching hospital.
    Haines JM; Ngwenyama TR; Martin LG; Wardrop KJ
    J Vet Emerg Crit Care (San Antonio); 2022 May; 32(3):315-321. PubMed ID: 35001463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefit of prestorage leukocyte depletion of single-donor platelet concentrates.
    Chalandon Y; Mermillod B; Beris P; Doucet A; Chapuis B; Roux-Lombard P; Dayer JM
    Vox Sang; 1999; 76(1):27-37. PubMed ID: 9933851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations.
    Klüter H; Bubel S; Kirchner H; Wilhelm D
    Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of premedication guidelines and leukoreduction on the rate of febrile nonhaemolytic platelet transfusion reactions.
    Patterson BJ; Freedman J; Blanchette V; Sher G; Pinkerton P; Hannach B; Meharchand J; Lau W; Boyce N; Pinchefsky E; Tasev T; Pinchefsky J; Poon S; Shulman L; MacK P; Thomas K; Blanchette N; Greenspan D; Panzarella T
    Transfus Med; 2000 Sep; 10(3):199-206. PubMed ID: 10972914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Our experience in riboflavin and ultraviolet light pathogen reduction technology for platelets: from platelet production to patient care.
    Jimenez-Marco T; Garcia-Recio M; Girona-Llobera E
    Transfusion; 2018 Aug; 58(8):1881-1889. PubMed ID: 30132911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen-reduced platelets.
    Bahar B; Schulz WL; Gokhale A; Spencer BR; Gehrie EA; Snyder EL
    Br J Haematol; 2020 Feb; 188(3):465-472. PubMed ID: 31566724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From 2007 to 2013.
    Andreu G; Boudjedir K; Muller JY; Pouchol E; Ozier Y; Fevre G; Gautreau C; Quaranta JF; Drouet C; Rieux C; Mertes PM; Clavier B; Carlier M; Sandid I
    Transfus Med Rev; 2018 Jan; 32(1):16-27. PubMed ID: 28864336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
    Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
    Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion.
    Blajchman MA; Bardossy L; Carmen RA; Goldman M; Heddle NM; Singal DP
    Blood; 1992 Mar; 79(5):1371-5. PubMed ID: 1536960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.
    Federowicz I; Barrett BB; Andersen JW; Urashima M; Popovsky MA; Anderson KC
    Transfusion; 1996 Jan; 36(1):21-8. PubMed ID: 8607149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN
    Poston JN; Sugalski J; Gernsheimer TB; Marc Stewart F; Pagano MB
    Vox Sang; 2020 May; 115(4):334-338. PubMed ID: 32080868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.